CorMedix Inc ROA 2011-2020 | CRMD

Current and historical return on assets (ROA) values for CorMedix Inc (CRMD) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
CorMedix Inc ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-09-30 $-0.05B $0.04B -163.33%
2020-06-30 $-0.05B $0.02B -164.91%
2020-03-31 $-0.04B $0.03B -149.15%
2019-12-31 $-0.04B $0.03B -145.76%
2019-09-30 $-0.01B $0.03B -33.33%
2019-06-30 $-0.01B $0.03B -68.29%
2019-03-31 $-0.02B $0.03B -146.67%
2018-12-31 $-0.03B $0.02B -251.16%
2018-09-30 $-0.04B $0.01B -421.62%
2018-06-30 $-0.04B $0.01B -362.79%
2018-03-31 $-0.04B $0.01B -241.38%
2017-12-31 $-0.03B $0.01B -209.52%
2017-09-30 $-0.03B $0.01B -166.67%
2017-06-30 $-0.03B $0.02B -133.33%
2017-03-31 $-0.03B $0.02B -119.59%
2016-12-31 $-0.03B $0.02B -86.21%
2016-09-30 $-0.02B $0.03B -67.18%
2016-06-30 $-0.02B $0.03B -51.06%
2016-03-31 $-0.02B $0.03B -45.64%
2015-12-31 $-0.02B $0.04B -57.60%
2015-09-30 $-0.02B $0.04B -68.82%
2015-06-30 $-0.02B $0.04B -104.92%
2015-03-31 $-0.01B $0.01B -120.00%
2014-12-31 $-0.02B $0.01B -280.00%
2014-09-30 $-0.02B $0.01B -314.29%
2014-06-30 $-0.02B $0.01B -363.64%
2014-03-31 $-0.03B $0.01B -714.29%
2013-12-31 $-0.01B $0.00B -1000.00%
2013-09-30 $-0.01B $0.00B -1600.00%
2013-06-30 $-0.01B $0.00B -1200.00%
2013-03-31 $-0.01B $0.00B -666.67%
2012-12-31 $-0.00B $0.00B -533.33%
2012-09-30 $-0.00B $0.00B -240.00%
2012-06-30 $-0.01B $0.00B -285.71%
2012-03-31 $-0.01B $0.00B -218.18%
2011-12-31 $-0.01B $0.00B -155.56%
2011-09-30 $-0.01B $0.00B -150.00%
2011-06-30 $-0.01B $0.01B -90.32%
2011-03-31 $-0.01B $0.01B -64.86%
2010-12-31 $-0.01B $0.01B -104.76%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.228B $0.000B
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. Defencath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product, which provides an additional five years of marketing exclusivity, which will be added to the five years granted to a New Chemical Entity upon approval of the NDA. CorMedix also intends to develop Defencath as a catheter lock solution for use in oncology and total parenteral nutrition patients. It is leveraging its taurolidine technology to develop a pipeline of antimicrobial medical devices, with programs in surgical sutures and meshes, and topical hydrog
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.950B 9.21
Amgen (AMGN) United States $128.168B 13.37
CSL (CSLLY) Australia $89.421B 0.00
Gilead Sciences (GILD) United States $79.454B 8.92
Illumina (ILMN) United States $58.303B 88.80
Vertex Pharmaceuticals (VRTX) United States $54.017B 22.96
Moderna (MRNA) United States $52.890B 0.00
Regeneron Pharmaceuticals (REGN) United States $48.143B 15.73
Biogen (BIIB) United States $40.151B 8.03
Alexion Pharmaceuticals (ALXN) United States $32.639B 12.71
BeiGene (BGNE) Cayman Islands $26.456B 0.00
Seagen (SGEN) United States $26.350B 45.17
BioNTech SE (BNTX) Germany $22.911B 0.00
Exact Sciences (EXAS) United States $20.464B 0.00
Genmab (GMAB) Denmark $20.267B 28.37
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.827B 0.00
Horizon Therapeutics Public (HZNP) Ireland $19.311B 22.16
Genmab (GNMSF) Denmark $18.450B 4.37
Bio-Rad Laboratories (BIO.B) United States $17.927B 57.05
Incyte (INCY) United States $17.038B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.073B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.883B 110.65
ARGENX SE-ADR (ARGX) Netherlands $13.790B 0.00
Bio-Techne Corp (TECH) United States $13.498B 77.31
Guardant Health (GH) United States $13.372B 0.00
Zai Lab (ZLAB) China $11.713B 0.00
Novavax (NVAX) United States $11.677B 0.00
QIAGEN (QGEN) Netherlands $10.836B 22.13
Repligen (RGEN) United States $10.035B 110.37
Mirati Therapeutics (MRTX) United States $9.165B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.711B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.942B 0.00
Fate Therapeutics (FATE) United States $7.797B 0.00
Acceleron Pharma (XLRN) United States $7.744B 0.00
Ascendis Pharma (ASND) Denmark $7.663B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.333B 0.00
Denali Therapeutics (DNLI) United States $7.102B 225.77
Exelixis (EXEL) United States $6.649B 60.89
Sarepta Therapeutics (SRPT) United States $6.525B 0.00
Adaptive Biotechnologies (ADPT) United States $6.081B 0.00
Twist Bioscience (TWST) United States $5.673B 0.00
Galapagos (GLPG) Belgium $5.552B 0.00
Halozyme Therapeutics (HALO) United States $5.467B 44.90
Blueprint Medicines (BPMC) United States $5.333B 17.56
NeoGenomics (NEO) United States $5.285B 645.57
Vir Biotechnology (VIR) United States $5.071B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $4.890B 15.38
Emergent Biosolutions (EBS) United States $4.843B 11.58
Biohaven Pharmaceutical Holding (BHVN) United States $4.821B 0.00
Certara (CERT) United States $4.669B 0.00
China Biologic Products (CBPO) China $4.647B 30.12
Arena Pharmaceuticals (ARNA) United States $4.315B 0.00
Reata Pharmaceuticals (RETA) United States $4.263B 0.00
Beam Therapeutics (BEAM) United States $4.260B 0.00
I-Mab (IMAB) China $3.997B 0.00
Insmed (INSM) United States $3.842B 0.00
Intellia Therapeutics (NTLA) United States $3.686B 0.00
Apellis Pharmaceuticals (APLS) United States $3.669B 0.00
Arvinas (ARVN) United States $3.474B 0.00
Berkeley Lights (BLI) United States $3.458B 0.00
SpringWorks Therapeutics (SWTX) United States $3.394B 0.00
MorphoSys AG (MOR) Germany $3.171B 114.76
Legend Biotech (LEGN) United States $3.109B 0.00
Viela Bio (VIE) United States $2.910B 0.00
Alkermes (ALKS) Ireland $2.900B 0.00
NantKwest (NK) United States $2.807B 0.00
Amicus Therapeutics (FOLD) United States $2.736B 0.00
Editas Medicine (EDIT) United States $2.719B 0.00
Intra-Cellular Therapies (ITCI) United States $2.692B 0.00
Global Blood Therapeutics (GBT) United States $2.507B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.476B 0.00
Sorrento Therapeutics (SRNE) United States $2.474B 0.00
Arcus Biosciences (RCUS) United States $2.367B 0.00
Ligand Pharmaceuticals (LGND) United States $2.354B 44.56
Morphic Holding (MORF) United States $2.242B 0.00
Amarin (AMRN) Ireland $2.224B 0.00
PHARMA MAR SA (PHMMF) Spain $2.211B 0.00
Myriad Genetics (MYGN) United States $2.138B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.065B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.987B 16.45
Genetron Holdings (GTH) China $1.916B 0.00
Inovio Pharmaceuticals (INO) United States $1.900B 0.00
Bluebird Bio (BLUE) United States $1.876B 0.00
NGM Biopharmaceuticals (NGM) United States $1.864B 0.00
Vericel (VCEL) United States $1.857B 808.20
Revance Therapeutics (RVNC) United States $1.835B 0.00
Pandion Therapeutics (PAND) United States $1.815B 0.00
Scholar Rock Holding (SRRK) United States $1.702B 0.00
Precigen (PGEN) United States $1.684B 0.00
REGENXBIO (RGNX) United States $1.666B 0.00
Seres Therapeutics (MCRB) United States $1.653B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.637B 0.00
Sangamo Therapeutics (SGMO) United States $1.609B 0.00
Travere Therapeutics (TVTX) United States $1.587B 0.00
Heska (HSKA) United States $1.582B 0.00
UniQure (QURE) Netherlands $1.483B 0.00
Zymeworks (ZYME) Canada $1.474B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.446B 0.00
Five Prime Therapeutics (FPRX) United States $1.445B 0.00
Frequency Therapeutics (FREQ) United States $1.406B 0.00
Castle Biosciences (CSTL) United States $1.376B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.376B 0.00
Zealand Pharma (ZEAL) Denmark $1.346B 0.00
Cytokinetics (CYTK) United States $1.321B 0.00
Alector (ALEC) United States $1.293B 0.00
Codexis (CDXS) United States $1.289B 0.00
Nurix Therapeutics (NRIX) United States $1.264B 0.00
Mersana Therapeutics (MRSN) United States $1.249B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.197B 0.00
Northwest Biotherapeutics (NWBO) United States $1.150B 0.00
Zealand Pharma (ZLDPF) Denmark $1.141B 0.00
Pliant Therapeutics (PLRX) United States $1.140B 0.00
MiMedx (MDXG) United States $1.118B 0.00
Coherus BioSciences (CHRS) United States $1.110B 9.02
Mesoblast (MESO) Australia $1.079B 0.00
Protagonist Therapeutics (PTGX) United States $1.075B 0.00
Adverum Biotechnologies (ADVM) United States $1.072B 0.00
Bionano Genomics (BNGO) United States $1.057B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.046B 0.00
Repare Therapeutics (RPTX) Canada $1.008B 0.00
Celldex Therapeutics (CLDX) United States $0.997B 0.00
Avid Bioservices (CDMO) United States $0.967B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.960B 40.67
Dynavax Technologies (DVAX) United States $0.959B 0.00
Epizyme (EPZM) United States $0.936B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.925B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.923B 0.00
Cara Therapeutics (CARA) United States $0.902B 226.00
G1 THERAPEUTICS (GTHX) United States $0.852B 0.00
Prothena (PRTA) Ireland $0.847B 0.00
Pharming Group (PHGUF) Netherlands $0.838B 22.32
Pharming Group (PHAR) $0.838B 0.00
MannKind (MNKD) United States $0.835B 0.00
Cellectis S.A (CLLS) France $0.820B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.807B 0.00
Kadmon Holdings (KDMN) United States $0.798B 0.00
Sutro Biopharma (STRO) United States $0.783B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.777B 0.00
AnaptysBio (ANAB) United States $0.770B 0.00
Cel-Sci (CVM) United States $0.743B 0.00
VBI Vaccines (VBIV) United States $0.721B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.708B 0.00
Merus (MRUS) Netherlands $0.680B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.667B 0.00
ALBIREO PHARMA (ALBO) United States $0.647B 0.00
Starpharma Holdings (SPHRY) Australia $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Intercept Pharmaceuticals (ICPT) United States $0.638B 0.00
Agenus (AGEN) United States $0.601B 0.00
ChromaDex (CDXC) United States $0.592B 0.00
Clovis Oncology (CLVS) United States $0.592B 0.00
Precision BioSciences (DTIL) United States $0.578B 0.00
Compugen (CGEN) Israel $0.558B 0.00
DBV Technologies S.A (DBVT) France $0.551B 0.00
Geron (GERN) United States $0.550B 0.00
Anika Therapeutics (ANIK) United States $0.542B 181.57
Curis (CRIS) United States $0.537B 0.00
MeiraGTx Holdings (MGTX) United States $0.534B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
AC Immune SA (ACIU) Switzerland $0.526B 0.00
Gritstone Oncology (GRTS) United States $0.513B 0.00
Amryt Pharma (AMYT) United Kingdom $0.499B 0.00
Neoleukin Therapeutics (NLTX) United States $0.479B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.477B 0.00
AMMO (POWW) United States $0.458B 0.00
WAVE Life Sciences (WVE) Singapore $0.456B 0.00
Affimed (AFMD) Germany $0.453B 0.00
Syros Pharmaceuticals (SYRS) United States $0.447B 0.00
Spero Therapeutics (SPRO) United States $0.438B 0.00
Kala Pharmaceuticals (KALA) United States $0.436B 0.00
Puma Biotechnology (PBYI) United States $0.431B 0.00
AquaBounty Technologies (AQB) United States $0.429B 0.00
Athenex (ATNX) United States $0.419B 0.00
Selecta Biosciences (SELB) United States $0.412B 0.00
Fulcrum Therapeutics (FULC) United States $0.408B 0.00
BioDelivery Sciences (BDSI) United States $0.406B 19.14
UROGEN PHARMA (URGN) United States $0.396B 0.00
Opthea (OPT) Australia $0.395B 0.00
XOMA (XOMA) United States $0.390B 0.00
Kaleido Biosciences (KLDO) $0.389B 0.00
Fortress Biotech (FBIO) United States $0.387B 0.00
Verastem (VSTM) United States $0.377B 0.00
Cue Biopharma (CUE) United States $0.371B 0.00
Athersys (ATHX) United States $0.364B 0.00
CytomX Therapeutics (CTMX) United States $0.351B 0.00
ANI Pharmaceuticals (ANIP) United States $0.351B 8.93
Aeglea BioTherapeutics (AGLE) United States $0.343B 0.00
Forte Biosciences (FBRX) United States $0.340B 0.00
Cardiff Oncology (CRDF) United States $0.340B 0.00
Innate Pharma S.A (IPHA) France $0.340B 0.00
Trevena (TRVN) United States $0.327B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.324B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.322B 0.00
Oncobiologics (OTLK) United States $0.314B 0.00
NextCure (NXTC) United States $0.314B 0.00
IBio (IBIO) United States $0.309B 0.00
Bellus Health (BLU) Canada $0.309B 0.00
Theratechnologies (THTX) Canada $0.294B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.279B 0.00
Kamada (KMDA) Israel $0.268B 15.44
Arbutus Biopharma (ABUS) United States $0.267B 0.00
Evofem Biosciences (EVFM) United States $0.266B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.264B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.262B 0.00
HOOKIPA Pharma (HOOK) United States $0.252B 0.00
Cerecor (CERC) United States $0.242B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.235B 0.00
TELA Bio (TELA) United States $0.229B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.225B 0.00
OSMOTICA PHARM (OSMT) United States $0.218B 0.00
Applied Genetic Technologies (AGTC) United States $0.216B 0.00
ADMA Biologics Inc (ADMA) United States $0.211B 0.00
Voyager Therapeutics (VYGR) United States $0.210B 5.87
INmune Bio (INMB) United States $0.207B 0.00
Abeona Therapeutics (ABEO) United States $0.205B 0.00
Aptinyx (APTX) United States $0.202B 0.00
Chiasma (CHMA) United States $0.199B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Checkpoint Therapeutics (CKPT) United States $0.196B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.192B 0.00
GENFIT S.A (GNFT) France $0.189B 0.00
Strongbridge Biopharma (SBBP) United States $0.187B 0.00
Eton Pharmaceuticals (ETON) United States $0.187B 0.00
VolitionRX (VNRX) United States $0.182B 0.00
Exicure (XCUR) United States $0.181B 0.00
Idera Pharmaceuticals (IDRA) United States $0.179B 0.00
Nicox SA (NICXF) France $0.177B 0.00
Kindred Biosciences (KIN) United States $0.173B 0.00
Orgenesis (ORGS) United States $0.170B 352.00
Pluristem Therapeutics (PSTI) Israel $0.169B 0.00
VTv Therapeutics (VTVT) United States $0.167B 0.00
Antibe Therapeutics (ATBPF) Canada $0.166B 0.00
DiaMedica Therapeutics (DMAC) United States $0.162B 0.00
Palatin Technologies (PTN) United States $0.161B 0.00
Clearside Biomedical (CLSD) United States $0.157B 0.00
Protalix BioTherapeutics (PLX) Israel $0.151B 0.00
X4 Pharmaceuticals (XFOR) United States $0.150B 0.00
Cogent Biosciences (COGT) United States $0.145B 0.00
Aptevo Therapeutics (APVO) United States $0.144B 0.00
Seelos Therapeutics (SEEL) United States $0.142B 0.00
Biofrontera AG (BFRA) Germany $0.141B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.140B 0.00
Dyadic (DYAI) United States $0.136B 0.00
Enzo Biochem (ENZ) United States $0.132B 0.00
Aytu Bioscience (AYTU) United States $0.131B 0.00
Catalyst Biosciences (CBIO) United States $0.130B 0.00
Cyclerion Therapeutics (CYCN) United States $0.128B 0.00
TRACON Pharmaceuticals (TCON) United States $0.126B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.126B 0.00
Evogene (EVGN) Israel $0.122B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.120B 0.00
Liminal BioSciences (LMNL) Canada $0.118B 0.00
Prima BioMed (IMMP) Australia $0.118B 0.00
CytRx (CYTR) United States $0.116B 0.00
Liquidia Technologies (LQDA) United States $0.115B 0.00
Cidara Therapeutics (CDTX) United States $0.112B 0.00
Beyond Air (XAIR) United States $0.112B 0.00
Lumos Pharma (LUMO) United States $0.112B 0.00
Ecology Coatings (ABVC) United States $0.110B 0.00
Synlogic (SYBX) United States $0.108B 0.00
PHASEBIO PHARMA (PHAS) United States $0.107B 0.00
ARAVIVE, INC (ARAV) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.103B 0.00
Cocrystal Pharma (COCP) United States $0.095B 0.00
Adocia (ADOCY) France $0.092B 0.00
Novogen (KZIA) Australia $0.089B 0.00
Vascular Biogenics (VBLT) Israel $0.086B 0.00
AIkido Pharma (AIKI) United States $0.083B 0.00
Stealth BioTherapeutics (MITO) United States $0.083B 37.25
Organovo Holdings (ONVO) United States $0.081B 0.00
Advaxis (ADXS) United States $0.079B 0.00
Cleveland BioLabs (CBLI) United States $0.079B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.073B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.070B 0.00
Emmaus Life Sciences (EMMA) United States $0.070B 0.00
AEterna Zentaris (AEZS) United States $0.070B 0.00
Celsion (CLSN) United States $0.069B 0.00
Windtree Therapeutics (WINT) United States $0.068B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
Edesa Biotech (EDSA) Canada $0.066B 0.00
Purple Biotech (PPBT) Israel $0.064B 0.00
ZIVO Bioscience (ZIVO) United States $0.063B 0.00
Genetic Technologies (GENE) Australia $0.062B 0.00
ARIDIS PHARMACT (ARDS) United States $0.057B 0.00
Acorda Therapeutics (ACOR) United States $0.054B 0.96
Viracta Therapeutics (VIRX) United States $0.054B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
ATyr Pharma (LIFE) United States $0.045B 0.00
Enveric Biosciences (ENVB) United States $0.045B 0.00
Yumanity Therapeutics (YMTX) United States $0.044B 0.00
BioCardia (BCDA) United States $0.043B 0.00
Alimera Sciences (ALIM) United States $0.039B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.036B 0.00
IMMURON (IMRN) Australia $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.030B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Timber Pharmaceuticals (TMBR) United States $0.020B 0.00
Seneca Biopharma (SNCA) United States $0.019B 0.00
ThermoGenesis Holdings (THMO) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
Cyclo Therapeutics (CYTH) United States $0.013B 0.00
Benitec Biopharma (BNTC) United States $0.012B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00